205 related articles for article (PubMed ID: 22508516)
1. A humanized pattern of aromatase expression is associated with mammary hyperplasia in mice.
Zhao H; Pearson EK; Brooks DC; Coon JS; Chen D; Demura M; Zhang M; Clevenger CV; Xu X; Veenstra TD; Chatterton RT; DeMayo FJ; Bulun SE
Endocrinology; 2012 Jun; 153(6):2701-13. PubMed ID: 22508516
[TBL] [Abstract][Full Text] [Related]
2. Weight gain increases human aromatase expression in mammary gland.
Chen D; Zhao H; Coon JS; Ono M; Pearson EK; Bulun SE
Mol Cell Endocrinol; 2012 May; 355(1):114-20. PubMed ID: 22342815
[TBL] [Abstract][Full Text] [Related]
3. Estrogen production and action.
Nelson LR; Bulun SE
J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S116-24. PubMed ID: 11511861
[TBL] [Abstract][Full Text] [Related]
4. Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.
Tekmal RR; Kirma N; Gill K; Fowler K
Endocr Relat Cancer; 1999 Jun; 6(2):307-14. PubMed ID: 10731124
[TBL] [Abstract][Full Text] [Related]
5. Sources of estrogen and their importance.
Simpson ER
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):225-30. PubMed ID: 14623515
[TBL] [Abstract][Full Text] [Related]
6. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
7. A doxycycline-inducible, tissue-specific aromatase-expressing transgenic mouse.
Chow JD; Price JT; Bills MM; Simpson ER; Boon WC
Transgenic Res; 2012 Apr; 21(2):415-28. PubMed ID: 21614586
[TBL] [Abstract][Full Text] [Related]
8. Mammary gland development in transgenic male mice expressing human P450 aromatase.
Li X; Wärri A; Mäkelä S; Ahonen T; Streng T; Santti R; Poutanen M
Endocrinology; 2002 Oct; 143(10):4074-83. PubMed ID: 12239119
[TBL] [Abstract][Full Text] [Related]
9. Aromatase overexpression transgenic mice model: cell type specific expression and use of letrozole to abrogate mammary hyperplasia without affecting normal physiology.
Mandava U; Kirma N; Tekmal RR
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):27-34. PubMed ID: 11850204
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional control of local estrogen formation by aromatase in the breast.
To SQ; Knower KC; Cheung V; Simpson ER; Clyne CD
J Steroid Biochem Mol Biol; 2015 Jan; 145():179-86. PubMed ID: 24846828
[TBL] [Abstract][Full Text] [Related]
11. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice.
Tekmal RR; Liu YG; Nair HB; Jones J; Perla RP; Lubahn DB; Korach KS; Kirma N
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):9-15. PubMed ID: 15955696
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
Kirma N; Gill K; Mandava U; Tekmal RR
Cancer Res; 2001 Mar; 61(5):1910-8. PubMed ID: 11280746
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.
Tekmal RR; Ramachandra N; Gubba S; Durgam VR; Mantione J; Toda K; Shizuta Y; Dillehay DL
Cancer Res; 1996 Jul; 56(14):3180-5. PubMed ID: 8764102
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
Rubin GL; Zhao Y; Kalus AM; Simpson ER
Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129
[TBL] [Abstract][Full Text] [Related]
16. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 and PKM2 Drive the Expression of Aromatase in Li-Fraumeni Syndrome Breast Adipose Stromal Cells.
Subbaramaiah K; Brown KA; Zahid H; Balmus G; Weiss RS; Herbert BS; Dannenberg AJ
J Biol Chem; 2016 Jul; 291(31):16011-23. PubMed ID: 27467582
[TBL] [Abstract][Full Text] [Related]
18. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
19. A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts.
Deb S; Zhou J; Amin SA; Imir AG; Yilmaz MB; Lin Z; Bulun SE
J Biol Chem; 2006 Feb; 281(5):2585-97. PubMed ID: 16303757
[TBL] [Abstract][Full Text] [Related]
20. IL-10 suppresses TNF-α-induced expression of human aromatase gene in mammary adipose tissue.
Martínez-Chacón G; Brown KA; Docanto MM; Kumar H; Salminen S; Saarinen N; Mäkelä S
FASEB J; 2018 Jun; 32(6):3361-3370. PubMed ID: 29401621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
